<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bauer M</submitter><funding>Austrian Science Fund FWF</funding><pagination>1326-31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4189097</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>83(15)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To study the functional activity of the multidrug efflux transporter P-glycoprotein (Pgp) at the blood-brain barrier of patients with temporal lobe epilepsy using (R)-[(11)C]verapamil (VPM)-PET before and after temporal lobe surgery to assess whether postoperative changes in seizure frequency and antiepileptic drug load are associated with changes in Pgp function.&lt;h4>Methods&lt;/h4>Seven patients with drug-resistant temporal lobe epilepsy underwent VPM-PET scans pre- and postsurgery. Patients were followed up for a median of 6 years (range 4-7) after surgery. Pgp immunoreactivity in surgically resected hippocampal specimens was determined with immunohistochemistry.&lt;h4>Results&lt;/h4>Optimal surgical outcome, defined as seizure freedom and withdrawal of antiepileptic drugs, was</pubmed_abstract><journal>Neurology</journal><pubmed_title>In vivo P-glycoprotein function before and after epilepsy surgery.</pubmed_title><pmcid>PMC4189097</pmcid><funding_grant_id>F 3513</funding_grant_id><funding_grant_id>KLI 139</funding_grant_id><funding_grant_id>F 3513-B20</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Muller M</pubmed_authors><pubmed_authors>Zeitlinger M</pubmed_authors><pubmed_authors>Asselin MC</pubmed_authors><pubmed_authors>Sisodiya SM</pubmed_authors><pubmed_authors>Langer O</pubmed_authors><pubmed_authors>Bauer M</pubmed_authors><pubmed_authors>Mitterhauser M</pubmed_authors><pubmed_authors>Wadsak W</pubmed_authors><pubmed_authors>Hainfellner JA</pubmed_authors><pubmed_authors>Pataraia E</pubmed_authors><pubmed_authors>Karch R</pubmed_authors><pubmed_authors>Koepp MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>In vivo P-glycoprotein function before and after epilepsy surgery.</name><description>&lt;h4>Objectives&lt;/h4>To study the functional activity of the multidrug efflux transporter P-glycoprotein (Pgp) at the blood-brain barrier of patients with temporal lobe epilepsy using (R)-[(11)C]verapamil (VPM)-PET before and after temporal lobe surgery to assess whether postoperative changes in seizure frequency and antiepileptic drug load are associated with changes in Pgp function.&lt;h4>Methods&lt;/h4>Seven patients with drug-resistant temporal lobe epilepsy underwent VPM-PET scans pre- and postsurgery. Patients were followed up for a median of 6 years (range 4-7) after surgery. Pgp immunoreactivity in surgically resected hippocampal specimens was determined with immunohistochemistry.&lt;h4>Results&lt;/h4>Optimal surgical outcome, defined as seizure freedom and withdrawal of antiepileptic drugs, was</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Oct</publication><modification>2025-04-05T00:20:49.311Z</modification><creation>2019-03-27T01:37:11Z</creation></dates><accession>S-EPMC4189097</accession><cross_references><pubmed>25186858</pubmed><doi>10.1212/WNL.0000000000000858</doi></cross_references></HashMap>